Latest News & Features
Americas
A group of generics manufacturers yesterday, December 2 asked the US Court of Appeals for the Ninth Circuit to reverse California’s ban on pay-for-delay deals. 3 January 2020
Genetics
Gene-sequencing companies Illumina and Pacific Biosciences have “mutually agreed” to terminate their $1.2 million merger agreement, under which Illumina would have acquired PacBio. 3 January 2020
Americas
California-based Adamas Pharmaceuticals has entered into a settlement agreement with Novartis’ generics unit Sandoz over a treatment for dyskinesia, the involuntary movements in Parkinson’s disease patients. 3 January 2020
Americas
Eli Lilly has won a victory in a cancer drug dispute after a federal judge ruled that Canadian pharmaceutical company Apotex’s new drug application infringed the company’s patent. 2 January 2020
Americas
A New York-based cardiologist is suing Apple over the tech that allows the Apple Watch to detect irregular heart rhythms. 2 January 2020
Americas
The US Patent and Trademark Office has granted the University of California its 20th US patent on CRISPR-Cas9 gene-editing technologies. 2 January 2020
Big Pharma
Sandoz and Momenta have agreed to pay $120 million to bring an antitrust class action over blockbuster blood clot drug enoxaparin to an end. 24 December 2019
Americas
Johnson & Johnson has announced its plan to acquire the remaining stake in Verb Surgical, its robotics venture with Alphabet-owned Verily. 23 December 2019
Americas
Bayer has dropped trade secrets claims against a former employee and rival company, which it had accused of stealing confidential information related to organic fungicides. 23 December 2019
Americas
Canadian pharmaceutical company Bausch Health and India-based Glenmark Pharmaceuticals have resolved their outstanding IP litigation over Bryhali lotion. 23 December 2019